Activity
-
Fantastic achievement by Michael Quirmbach and the whole CordenPharma team!
Fantastic achievement by Michael Quirmbach and the whole CordenPharma team!
Liked by Julia Monfrini Peev
-
Incredible quantum news. Today, JB Pritzker is announcing a game-changing partnership between Defense Advanced Research Projects Agency (DARPA) and…
Incredible quantum news. Today, JB Pritzker is announcing a game-changing partnership between Defense Advanced Research Projects Agency (DARPA) and…
Liked by Julia Monfrini Peev
-
Platform Award recipient Brendan Fernandes is a multidisciplinary artist examining issues of cultural displacement, migration, labor, and queer…
Platform Award recipient Brendan Fernandes is a multidisciplinary artist examining issues of cultural displacement, migration, labor, and queer…
Liked by Julia Monfrini Peev
Experience & Education
-
AMOpportunities
View Julia’s full experience
See their title, tenure and more.
or
Volunteer Experience
-
-
-
-
-
Advisor
Docutribe
- Present 8 years 4 months
Education
-
-
Finance Committee, Assistant Treasurer
PEWIN - Private Equity Women Investor Network
- Present 1 year 11 months
Civil Rights and Social Action
Publications
More activity by Julia
-
I commend Sterling Bay and its CEO, Andy Gloor, for their unwavering commitment to the development of Lincoln Yards. In today’s open letter to…
I commend Sterling Bay and its CEO, Andy Gloor, for their unwavering commitment to the development of Lincoln Yards. In today’s open letter to…
Liked by Julia Monfrini Peev
-
We are excited to announce that our Executive Director, Michelle Burbea Hoffmann will be speaking at the TechRise BioTech & Life Sciences Pitch…
We are excited to announce that our Executive Director, Michelle Burbea Hoffmann will be speaking at the TechRise BioTech & Life Sciences Pitch…
Liked by Julia Monfrini Peev
-
On behalf of our Investment Committee (and joined by my colleagues Greg Deeds, CFA and Shawn Dearey) I'm thrilled to have the opportunity to announce…
On behalf of our Investment Committee (and joined by my colleagues Greg Deeds, CFA and Shawn Dearey) I'm thrilled to have the opportunity to announce…
Liked by Julia Monfrini Peev
-
We're thrilled to announce the distinguished panel of judges for our Life Sciences and Biotech TechRise Chicago Pitch Competition happening on…
We're thrilled to announce the distinguished panel of judges for our Life Sciences and Biotech TechRise Chicago Pitch Competition happening on…
Liked by Julia Monfrini Peev
-
While I’m proud of this milestone and all the work our team has done in publishing impactful research, it is also a reminder of how much more work we…
While I’m proud of this milestone and all the work our team has done in publishing impactful research, it is also a reminder of how much more work we…
Liked by Julia Monfrini Peev
-
My first Crain's Chicago Business’ column has been published! As part of my Beyond the Status Quo project, this monthly column will feature 50…
My first Crain's Chicago Business’ column has been published! As part of my Beyond the Status Quo project, this monthly column will feature 50…
Liked by Julia Monfrini Peev
-
The next paper in the GLP1-RA series is the protocol for our clinical trial testing the impact of oral semaglutide on Alzheimer’s disease pathology…
The next paper in the GLP1-RA series is the protocol for our clinical trial testing the impact of oral semaglutide on Alzheimer’s disease pathology…
Liked by Julia Monfrini Peev
-
Take a look at John Flavin's interview on Yahoo Finance! John was interviewed by Julie Hyman and Josh Lipton to discuss GLP-1 and A.I.'s impact on…
Take a look at John Flavin's interview on Yahoo Finance! John was interviewed by Julie Hyman and Josh Lipton to discuss GLP-1 and A.I.'s impact on…
Liked by Julia Monfrini Peev
-
First in our series of three papers on GLP1 receptor agonists and dementia: in a study on US based electronic health records we show that semaglutide…
First in our series of three papers on GLP1 receptor agonists and dementia: in a study on US based electronic health records we show that semaglutide…
Liked by Julia Monfrini Peev
-
We’re delighted to announce the addition of Oxana Popova to our team. As Director of Research, she’s responsible for sourcing, due diligence and…
We’re delighted to announce the addition of Oxana Popova to our team. As Director of Research, she’s responsible for sourcing, due diligence and…
Liked by Julia Monfrini Peev
-
Aujourd'hui, aucun bloc n'a la majorité absolue à l'Assemblée nationale. La seule solution, c'est une coalition. L’urgence n’est pas de changer en…
Aujourd'hui, aucun bloc n'a la majorité absolue à l'Assemblée nationale. La seule solution, c'est une coalition. L’urgence n’est pas de changer en…
Liked by Julia Monfrini Peev
-
The results are IN! Alloy contracted an independent expert dermatologist investigator to conduct a double-blind, three-armed, placebo-controlled…
The results are IN! Alloy contracted an independent expert dermatologist investigator to conduct a double-blind, three-armed, placebo-controlled…
Liked by Julia Monfrini Peev
People also viewed
-
Jon David Willingham
Connect -
Liz Yuhas
Connect -
Lucy Reynales
Connect -
Dipa Mehta
Connect -
Cheryl Rucker-Whitaker MD, MPH
Value-Based Care| Board Director | Transforming Older Adult Care | Past President of Institute of Medicine Chicago | Physician-Entrepreneur | Health Equity Expert| Health Information Technology Leader | Public Speaker |
Connect -
Rashid Bashir
Connect -
Josh Miller
Connect -
Ashley Ryder
Connect -
Tashi Nakanishi
Connect -
Janis Naeve
Connect
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More